0001193125-18-233357.txt : 20180731 0001193125-18-233357.hdr.sgml : 20180731 20180731165705 ACCESSION NUMBER: 0001193125-18-233357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180731 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180731 DATE AS OF CHANGE: 20180731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 18981826 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d589878d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):    July 31, 2018

Commission File Number: 0-24260

 

 

Amedisys, Inc.

(Exact name of registrant as specified in charter)

 

 

Delaware   11-3131700
(State or other jurisdiction   (IRS Employer
of incorporation or organization)   Identification No.)

3854 American Way, Suite A, Baton Rouge, LA 70816

(Address of principal executive offices, including zip code)

(225) 292-2031 or (800) 467-2662

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

 

 


SECTION 7—REGULATION FD

 

Item 7.01. Regulation FD Disclosure.

On July 31, 2018, Amedisys, Inc. (the “Company”) issued a press release announcing that its subsidiary, Associated Home Care, has signed a definitive agreement to acquire Bring Care Home, a personal care provider in northeastern Massachusetts, a copy of which is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) is being “furnished” and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of Section 18, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

SECTION 9—FINANCIAL STATEMENTS AND EXHIBITS

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
Number

  

Description

99.1    Press Release dated July 31, 2018


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.
By:   /s/ Paul B. Kusserow
Paul B. Kusserow
President and Chief Executive Officer
DATE: July 31, 2018
EX-99.1 2 d589878dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO   

Contact:

 

Kendra Kimmons

Vice President of Marketing & Communications

225-299-3708

kendra.kimmons@amedisys.com

Amedisys Signs Definitive Agreement to Acquire Bring Care Home

BATON ROUGE, La., July 31, 2018 – Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home Care, has signed a definitive agreement to acquire Bring Care Home, a personal care provider in northeastern Massachusetts.

Under the terms of the agreement, Associated Home Care will acquire substantially all assets of Bring Care Home.

Bring Care Home is a privately owned company providing personalized, one-on-one quality care to clients in the North Shore, Merrimack Valley and Greater Boston areas. The company provides personal care, live-in home care, companionship, transportation and skilled nursing to clients.

“Expanding our footprint in Massachusetts, a state in which we provide our three service lines of home health, hospice and personal care, is an important component of our growth strategy,” stated Amedisys President and CEO Paul Kusserow. “I look forward to welcoming these home care professionals into the Amedisys family of caregivers.”

The Amedisys Personal Care Division provides individualized, compassionate care to clients in Massachusetts and the areas surrounding Knoxville, Tennessee and Jacksonville, Florida.

Forward-Looking Statements:

When included in this press release, words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to identify forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a variety of risks and uncertainties that could cause actual results to differ materially from those described therein. These risks and uncertainties include, but are not limited to the following: changes in Medicare and other medical payment levels, our ability to open care centers, acquire additional care centers and integrate and operate these care centers effectively, changes in or our failure to comply with existing Federal and State laws or regulations or the inability to comply with new government regulations on a timely basis, competition in the healthcare industry, our ability to integrate our personal care segment into our business efficiently, changes in the case mix of patients and payment methodologies, changes in estimates and judgments associated with critical accounting policies, our ability to maintain or establish new patient referral sources, our ability to attract and retain qualified personnel, changes in payments and covered services due to the economic downturn and deficit spending by federal and state governments, future cost containment initiatives undertaken by third-party payors, our access to financing, our ability to meet debt service requirements and comply with covenants in debt agreements, business disruptions due to natural disasters or acts of terrorism, our ability to integrate,


manage and keep our information systems secure, our ability to comply with requirements stipulated in our corporate integrity agreement and changes in law or developments with respect to any litigation relating to the Company, including various other matters, many of which are beyond our control.

Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on any forward-looking statement as a prediction of future events. We expressly disclaim any obligation or undertaking and we do not intend to release publicly any updates or changes in our expectations concerning the forward-looking statements or any changes in events, conditions or circumstances upon which any forward-looking statement may be based, except as required by law.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. We partner with 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With 18,300 employees in 420 care centers in 34 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 369,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com.

#     #     #

GRAPHIC 3 g589878g30q11.jpg GRAPHIC begin 644 g589878g30q11.jpg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end